CASP3 and non-small cell lung carcinoma: In our study, the results of the survival analysis of key genes showed that AKT1, MAPK1, CASP3, MMP9, TP53, and PTGS2 had statistical differences in the OS or RFS of NSCLC patients (p < 0.05) (Figure 8).